DeviceTalks Podcast Network

In this episode of Boston Scientific Talks, Boston Scientific's Cat Jennings, President of Peripheral Vascular, and Dave Knapp, VP of R&D, discuss how they are working together to develop new products and technologies that will help patients with peripheral vascular disease, and how they are leveraging data and analytics to drive innovation. They also share their perspectives on the challenges...

In this episode, Tom Salemi interviews Mark Dickinson, worldwide president at Cerenovus, the neurovascular business at Johnson & Johnson Medtech. Mark Dickinson shares his unique entry into the medical device industry, how he built his career at the global company, and what the company is doing to develop its devices to treat stroke patients. In addition, we’ll also have interviews with Paul G...

In this episode of DeviceTalks Weekly, we visit with Claire Biot, vice president, life sciences at Dassault Systèmes to learn about the company’s virtual twin platform. Biot explains how the company is able to establish a digital model of a product requiring testing or patients who would serve as the test subject. The key benefits include faster product development, lower costs, higher sustainabil...

How concerned should you be about cybersecurity? And as an industry, how do we reduce the risk of using medical devices and potentially exposing our patients' personal data? In this episode, Drew Bomett, chief information security officer for Boston Scientific, discusses the importance of cybersecurity in the medical device industry and the unique challenges that come with securing medical devices...

In this week’s podcast, FundamentalVR co-founder and CEO Richard Vincent shares the opportunity and need that convinced him to cross the chasm from the tech industry to start a medtech-oriented VR company. Vincent also shares how FundamentalVR has advanced haptic technology to give training surgeons the ability to develop a true feel for surgery even when never touching a human body. FundamentalVR...

In this StrykerTalks podcast episode, CEO Kevin Lobo says he's seeing the skies are clearing a bit for the medical device industry and hospitals though challenges remain. Earnings are improving, and new product innovation is producing a super-cycle of new products. Listen now to hear Lobo's perspective on Stryker's position globally and in emerging markets, tailwinds from the COVID-19 pandemic, an...

In this week’s interview we talk with one of the newer orthopedics players on the block – Enovis, the entity formerly known as Colfax. CEO Matthew L. Trerotola walks us through the decision to move from a diversified industrial player into an orthopedics company and just how the company thinks it can compete against larger, established players in the market. Enovis is weighted heavily in extremiti...

We hand over the reins to all-around great Medtech guy and sales guru Omar M. Khateeb, host of the State of Medtech show on LinkedIn. Chris Newmarker, executive editor of MassDevice, brought along his latest Newmarker’s Newsmakers delivering news about iCad, Better Therapeutics, Philips, GE Healthcare, Masimo and Signifier Health. Chris, Omar and Tom Salemi, Editorial Director of DeviceTalks, shar...

In the premier episode of the new Boston Scientific Talks podcast series, we learn how Boston Scientific and IBM Research have joined together to address chronic pain - a physical, mental, and physiological condition affecting millions. Boston Scientific's Director R&D, Discovery: Data and Design, Matt McDonald and IBM Research's Global Research Leader, Jeff Rogers shared how the partnership i...

In this episode we’ll speak with two leaders of Ronovo Surgical, a Shanghai-based surgical robotics company that’s looking to challenge Intuitive and all comers to the massive surgical market in China. CEO John Ma and CTO Ying Mao describe the benefits they see in Ronovo Surgical’s unique modular system design. The pair bring experience from Intuitive, Auris, and other medical device companies. Wh...

In the first episode of IntuitiveTalks' newest season, Dave Rosa, who served as executive vice president and chief strategy and growth officer at the time of the interview, shares a look into the past and a glimpse into the future of Intuitive. What did Intuitive look like early on? How does Intuitive define itself today? And what direction is Intuitive heading to further embed itself into the min...

A week after the SVB Wall’s fall, we talk with medical device leaders about how they managed the run on Silicon Valley Bank, which filed for Chapter 11 bankruptcy procedure on the morning of the day this episode was published. Pristine Surgical CEO Bryan Lord recounts the steps his management team took after the news broke Thursday night. He also walks us through the 10-point plan that he posted o...

In this podcast episode, Co-Hosts Tom Salemi and Chris Newmarker review how the medtech industry is handing the current shrinking job market. They’ll review this week’s Newmarker’s Newsmakers which includes Medtronic, Biosense Webster, Johnson & Johnson and high profile clinical meetings. Tom then interviews Mike Dineen, CEO of Tioga Cardiovascular, which is pushing the limits for heart valves...

In this episode, Annie Heath, Stryker’s vice president of diversity, equity and inclusion, explains how an interest in sales brought her to Stryker where she held positions in operations for most of her career. Heath also shares how her personal story inspired her to pursue a role leading Stryker’s DEI effort. In addition to building a more diverse workforce, Stryker is also collaborating with sup...

Medtech layoffs continue to mount. We’ll use this episode to begin to explore external and internal challenges. Looking externally, longtime industry watcher Henry Soch, now an executive-in-residence at Matter, shares his concerns about the current and future ability of medical device companies – both big and small – getting new technologies into hospitals. You can read Soch’s blog post here. http...

In this week’s episode, we’ll hear pitches from the 10 start-ups that have been selected as finalists for Medtech Color’s Pitch Competition. BIOMED – Bobby Ntoya IllumifyDx - Maria Navas-Moreno JuneBrain – Samantha Scott Level 42 AI – Shash Jumbe Movement Interactive – Eric Luster Navigate Maternity – Ariana McGee Oben Health – Peter Njongwe Tanzen Medical – Nilanjan Banerjee, Justin Brooks Therma...

Wow, I think we have a cool new format for the podcast! This was a fun one! Holly Scott, vice president and senior partner of the Mullings Group, an executive search firm, shared her industry expertise and insights during Chris Newmarker’s Newsmakers. We covered a lot of ground there while reviewing news from Baxter, Medtronic, Titan Medical, Apple, as well as the many companies that reported layo...

The weekend ended with a bang as Abbott and Globus Medical both announced significant deals. Abbott picked up publicly traded Cardiovascular Solutions for $890 million while Globus Medical acquired – or merged if you prefer – with publicly held spine competitor NuVasive in a deal valued more than $3 billion. In this week’s episode, host Tom Salemi explores each deal with Wall Street Analysts Mike...

Murthy Simhambhatla launched his medtech career during the epic race to develop groundbreaking drug-eluting stent technologies as a new approach to battling cardiovascular disease. Over two decades later, following a career that took him across the globe and clinical specialities, Simhambhatla finds himself involved in another exciting push to bring new technologies to bear on prevalent medical pr...

Robert Cohen has his eyes on the future of orthopedic surgery, but he brings a wealth of knowledge about its past as well. In this interview, Cohen reviews his long history in orthopedic surgery, dating back to his studies in college. Over his career, Cohen has had a role in materials, 3D-printing, and began working with MAKO Surgical several years before its acquisition by Stryker in 2013. Now Co...

In this week’s episode, CEO Kevin Sayer takes a few minutes to share Dexcom’s vision for the future OUTSIDE of diabetes. What does this mean for people with diabetes and others who could benefit from the powerful Dexcom G7? We also bring in a very popular interview from our MedtronicTalks podcast series – Skip Kiil, president of cranial and spinal technologies, shares some very wise career advice...

Pristine Surgical CEO Bryan Lord spent his career advising and investing in medical device companies, so he didn’t immediately see how a “conspicuous outsider” like himself would be the right person to serve as CEO of start-up Pristine Surgical. But he immediately recognized the satisfaction in leading the company’s work to create first-of-its-kind 4K single-use surgical arthroscope designed for a...

Becton Dickinson’s CEO Tom Polen lays out the company’s plan for growth that’s building off a stunning sequence of acquisitions over the past two years that has the company loaded with tech – including digital and robotics tools – to drive its future growth. Polen also shares his tragic introduction to medtech and shares how that experiences influences every decision he makes. Tom Polen will be th...

In this episode, your diligent team of DeviceTalkers - Executive Editor Chris Newmarker, Pharma Editor Brian Buntz, Managing Editor Jim Hammerand, Senior Editor Danielle Kirsh, Associate Editor Sean Whooley and DeviceTalks Editorial Director Tom Salemi – assembled to review our Top 10 events, trends and newsmakers. We’ve got some highs – robots, diabetes – and some lows – Supply Chain, CPAP machin...

In this episode, we’ll speak with ReCor Medical’s CEO Andy Weiss and Helen Reeve-Stoffer, PHD, the company’s vice president of clinical affairs. The pair joined the renal denervation company in 2013, before disappointing results of a Medtronic-trial temporarily cratered the entire space. But now through careful clinical testing ReCor Medical is climbing out of that hole and demonstrating the techn...